Oncodesign Precision Medicine and Ksilink join forces to test the Nanocyclix® chemical library in cell models derived from patients with serious central nervous system diseases....
Strasbourg, France – Ksilink, together with our collaborators from I-Stem (Paris), has recently published a scientific paper that provides significant insights into...
New Study on the Impact of Endocrine Disrupting Chemicals on Parkinson’s Disease Ksilink, in collaboration with researchers from the University of Chieti in Italy, has published...
Thanks to the funding obtained from Horizon Europe, this research project aims to open up new therapeutic perspectives based on the results obtained from various disease models....
The Ksilink team is happy to participate today in the kick-off meeting of the EC-funded consortium EnvironMENTAL. The consortium, coordinated by the Charité Hospital and composed...
Based on our long-standing collaboration with myriamed GmbH and the successful establishment of an AI-powered screenable disease model for dilated cardiomyopathies, we proudly...
Credit : Broad Institute of MIT and Harvard. Human cells imaged using Cell Painting are treated with fluorescent dyes that mark different cellular components, including the...
Dr Juyong Yoon, Project team leader at Ksilink, published a paper entitled” Permissive epigenomes endow reprogramming competence to transcriptional regulators” in Nature chemical...
Ksilink is proud to announce that Ms Tiphaine Champetier has successfully passed her PhD viva. Ksilink is engaged in promoting young scientists in translational science and...
